Cell-Based Therapy in Chagas Disease

Advances in Parasitology

Volumn 75, Issue , 2011, Pages 49-63

  Campos de Carvalho, Antonio C ^a   Carvalho, Adriana B ^a   Goldenberg, Regina C S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cardiac diseases; Cardiomyopathy; Cell therapy; Chagas disease; Tripanosoma cruzi

Indexed keywords

BONE MARROW TRANSPLANTATION; BOOK; CELL HOMING; CELL THERAPY; CHAGAS DISEASE; CLINICAL TRIAL (TOPIC); EMBRYONIC STEM CELL; EXPERIMENTAL MODEL; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 79961013125     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385863-4.00003-4     Document Type: Chapter

References (69)

1. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
2. Andrade Z.A., Andrade S.G. Pathogenesis of Chagas chronic myocarditis: importance of ischemic lesions. Arq. Bras. Med. 1955, 45:279-288.
3. Andrade Z.A., Lopes E.A. A histochemical study of experimental Chagas disease. Rev. Inst. Med. Trop. Sao Paulo 1963, 5:236-242.
4. Ankrum J., Karp J.M. Mesenchymal stem cell therapy: two steps forward, one step back. Trends Mol. Med. 2010, 16:203-209.
5. Armaganijan L., Morillo C.A. Chagas disease: 101 years of solitude! Time for action. Stroke 2010, 41:2453-2454.
6. Assmus B., Schächinger V., Teupe C., Britten M., Lehmann R., Döbert N., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Circulation 2002, 106:3009-3017.
7. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
8. Barbosa da Fonseca L.M., Xavier S.S., Rosado de Castro P.H., Lima R.S., Gutfilen B., Goldenberg R.C., et al. Biodistribution of bone marrow mononuclear cells in chronic chagasic cardiomyopathy after intracoronary injection. Int. J. Cardiol. 2011, 149(3):310-314.
9. Barile L., Messina E., Giacomello A., Marbán E. Endogenous cardiac stem cells. Prog. Cardiovasc. Dis. 2007, 50:31-48.
10. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabé-Heider F., Walsh S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
11. Bern C., Montgomery S.P., Herwaldt B.L., Rassi A., Marin-Neto J.A., Dantas R.O., et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007, 298:2171-2181.
12. Bocchi E.A., Fiorelli A. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. Ann. Thorac. Surg. 2001, 71:1833-1838.
13. Cao F., Lin S., Xie X., Ray P., Patel M., Zhang X., et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 2006, 113:1005-1014.
14. Chagas C. Nova tripanosomíase humana: Estudos sobre a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n.g., n.sp., agente etiológico de nova entidade mórbida no homem. Mem. Inst. Oswaldo Cruz 1909, 1:159-218.
15. Autologous human cardiac-derived stem cell to treat ischemic cardiomyopathy (ALCADIA), Identifier NCT00981006 ClinicalTrials.gov. http://clinicaltrials.gov.
16. Cardiac stem cell infusion in patients with ischemic cardiomyopathy (SCIPIO), Identifier NCT00474461 ClinicalTrials.gov. http://clinicaltrials.gov.
17. Cardiosphere-derived autologous stem cells to reverse ventricular dysfunction (CADUCEUS), Identifier NCT00893360 ClinicalTrials.gov. http://clinicaltrials.gov.
18. Safety study of GRNOPC1 in spinal cord injury, Identifier NCT01217008 ClinicalTrials.gov. http://clinicaltrials.gov.
19. The BENEFIT Trial: evaluation of the use of an antiparasital drug (Benznidazole) in the treatment of chronic Chagas disease, Identifier NCT00123916 ClinicalTrials.gov. http://clinicaltrials.gov.
20. Dimmeler S., Zeiher A.M., Schneider M.D. Unchain my heart: the scientific foundations of cardiac repair. J. Clin. Invest. 2005, 115:572-583.
21. Freitas H.F., Chizolla P.R., Paes A.T., Lima A.C., Mansur A.J. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas heart disease. Int. J. Cardiol. 2005, 102:239-247.
22. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 2005, 11:367-368.
23. Goldenberg R.C., Jelicks L.A., Fortes F.S., Weiss L.M., Rocha L.L., Zhao D., et al. Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model. J. Infect. Dis. 2008, 197:544-547.
24. Goldenberg R.C., Iacobas D.A., Iacobas S., Rocha L.L., Fortes F.S., Vairo L., et al. Transcriptomic alterations in Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect. 2009, 11:1140-1149.
25. Guarita-Souza L.C., Carvalho K.A., Woitowicz V., Rebelatto C., Senegaglia A., Hansen P., et al. Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease. Circulation 2006, 114:I120-I124.
26. Hare J.M., Traverse J.H., Henry T.H., Dib N., Strumpf R.K., Schulman S.P., et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (Prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 2009, 54:2277-2286.
27. Hodgson D.M., Behfar A., Zingman L.V., Kane G.C., Perez-Terzic C., Alekseev A.E., et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am. J. Heart Circ. Physiol. 1994, 287:H471-H479.
28. Ieda M., Fu J.D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
29. Jacob J.L., Salis F.V., Ruiz M.A., Greco O.T. Labeled stem cells transplantation to the myocardium of a patient with Chagas disease. Arq. Bras. Cardiol. 2007, 89:e10-e11.
30. Karp J.M., Leng Teo G.S. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009, 6:206-216.
31. Kierszenbaum F. Where do we stand on the autoimmunity hypothesis of Chagas disease?. Trends Parasitol. 2005, 21:513-516.
32. Klug M.G., Soonpaa M.H., Koh G.Y., Field L.J. Genetically selected cardiomyocytes from differentiating embryonic stem cells forms stable intracardiac grafts. J. Clin. Invest. 1996, 98:216-224.
33. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001, 7:430-436.
34. Laflamme M.A., Murry C.E. Regenerating the heart. Nat. Biotechnol. 2005, 23:845-856.
35. Laflamme M.A., Gold J., Xu C., Hassanipour M., Rosler E., Police S., et al. Formation of human myocardium in the heart from human embryonic stem cells. Am. J. Pathol. 2005, 167:663-671.
36. Lanes-Vieira J., De Araújo-Jorge T.C., Soeiro Mde N., Gadelha P., Corrêa-Oliveira R. The centennial of the discovery of Chagas disease: facing the current challenges. PLoS Negl. Trop. Dis. 2010, 4:e645.
37. Le Blanc K., Rasmusson I., Sundberg B., Götherström C., Hassan M., Uzunel M., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363:1439-1441.
38. Lipinsky M.J., Biondi-Zoccai G.G., Abbate A., Khianey R., Sheiban I., Bartunek J., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J. Am. Coll. Cardiol. 2007, 50:1761-1767.
39. Macambira S.G., Vasconcelos J.F., Costa C.R., Klein W., Lima R.S., Guimarães P., et al. Granulocyte colony-stimulating factor treatment in chronic Chagas disease: preservation and improvement of cardiac structure and function. FASEB J. 2009, 23:3843-3850.
40. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 1999, 103:697-705.
41. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infracted hearts. Nat. Med. 2003, 9:1195-1201.
42. Martin-Rendon E., Brunskill S.J., Hyde C.J., Stanworth S.J., Mathur A., Watt S.M. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur. Heart J. 2008, 29:1807-1818.
43. Ménard C., Hagège A., Agbulut O., Barro M., Morichetti M.C., Brasselet C. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 2005, 366:1005-1012.
44. Menasché P. Stem cell therapy for heart failure: are arrhythmias a real safety concern?. Circulation 2009, 119:2735-2740.
45. Menasché P., Hagège A.A., Scorsin M., Pouzet B., Desnos M., Duboc D. Myoblast transplantation for heart failure. Lancet 2001, 357:279-280.
46. Menasché P., Alfieru O., Janssens S., McKenna W., Reichenspurner H., Trinquart L. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189-1200.
47. Moia B., Rosenbaum M.B. The electrocardiogram in chronic Chagas myocarditis. Arq. Bras. Cardiol. 1960, 13:236-243.
48. Mukherjee S., Belbin T.J., Spray D.C., Iacobas D.A., Weiss L.M., Kitsis R.N. Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol. Res. 2003, 91:187-196.
49. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
50. Nygren J.M., Jovinge S., Breitbach M., Sawen P., Roll W., Hescheler J., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 2004, 10:494-501.
51. Olivares E.L., Ribeiro V.P., Werneck-de-Castro J.P., Ribeiro K.C., Mattos E.C., Goldenberg R.C., et al. Bone marrow stromal cells improve cardiac performance in healed infracted rat hearts. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H464-H470.
52. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infracted myocardium. Nature 2001, 410:701-705.
53. Rassi A., Rassi A., Marin-Neto J.A. Chagas disease. Lancet 2010, 375:1388-1402.
54. Rosenbaum M.B. Chagasic myocardiopathy. Prog. Cardiovasc. Dis. 1964, 7:199-225.
55. Rosenbaum M.B., Alvarez A.J. The electrocardiogram in chronic chagasic myocarditis. Am. Heart J. 1955, 50:492-527.
56. Salvatella R. Current Status of Chagas Disease 2006, Pan American Health Organization, Washington, DC.
57. Soares M.B., Lima R.S., Rocha L.L., Takyia C.M., Pontes-de-Carvalho L., de Carvalho A.C., et al. Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. Am. J. Pathol. 2004, 164:441-447.
58. Soares M.B., de Lima R.S., Rocha L.L., Vasconcelos J.F., Rogatto S.R., dos Santos R.R., et al. Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy. J. Infect. Dis. 2010, 202:416-426.
59. Soares M.B., Lima R.S., Souza B.S.F., Vasconcelos J.F., Rocha L.L., dos Santos R.R., et al. Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells. Cell Cycle 2011, 10(9):1448-1455.
60. Soonpaa M.H., Daud A.I., Koh G.Y., Klug M.G., Kim K.K., Wang H., et al. Potential approaches for myocardial regeneration. Ann. N. Y. Acad. Sci. 1995, 752:446-454.
61. Stamm C., Westphal B., Kleine H.D., Petzsch M., Kittner H., Schümichen C., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003, 361:45-46.
62. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
63. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
64. Tomita S., Li R.K., Weisel R.D., Mickle D.A., Kim E.J., Sakai T., et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999, 100:II247-II256.
65. Vilas-Boas F., Feitosa G.S., Soares M.B., Mota A., Pinho-Filho J.A., Almeida A.J., et al. Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease. Arq. Bras. Cardiol. 2006, 87:159-166.
66. Wang J.S., Shum-Tim D., Galipeau J., Chedrawy E., Eliopoulos N., Chiu R.C. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J. Thorac. Cardiovasc. Surg. 2000, 120:999-1005.
67. Wang J.S., Shum-Tim D., Chedrawy E., Chiu R.C. The coronary delivery of stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J. Thorac. Cardiovasc. Surg. 2001, 122:699-705.
68. Wu X., Ding S., Ding Q., Gray N.S., Schultz P.G. Small molecules that induce cardiomyogenesis in embryonic stem cells. J. Am. Chem. Soc. 2004, 126:1590-1591.
69. Wu J.C., Abraham M.R., Kraitchman D.L. Current perspectives on imaging cardiac stem cell therapy. J. Nucl. Med. 2010, 51:128S-136S.